NCT01471496View on ClinicalTrials.gov

Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Duodenal Ulcer Bleeding
Interventions
PROCEDURE

prophylactic injection therapy

Standard application of endoscopic injection therapy as it is used for actively bleeding ulcers, 10 ml of serum saline with 1/10000 epinephrine is submucosally injected to the four quadrants of the ulcer margins.

Trial Locations (1)

34147

Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of General Surgery, Istanbul

All Listed Sponsors
lead

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

OTHER_GOV

NCT01471496 - Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers | Biotech Hunter | Biotech Hunter